Waters Corp (WAT) director reports new stock and option awards

Rhea-AI Filing Summary

Waters Corp director reports new stock awards. Director Christopher A. Kuebler reported receiving 307 shares of Waters Corp common stock on January 2, 2026 as a restricted stock grant at a price of $0 per share. These shares are subject to restrictions that lapse in full on January 2, 2027. Following this grant, he beneficially owns 17,785 common shares directly.

On the same date, he was granted a stock option covering 828 shares of common stock with an exercise price of $381.96 per share. All 828 option shares will vest and become exercisable on January 2, 2027, and the option expires on January 2, 2036. Both the stock and option holdings are reported as directly owned.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KUEBLER CHRISTOPHER A

(Last) (First) (Middle)

34 MAPLE STREET

(Street)

MILFORD MA 01757

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WATERS CORP /DE/ [ WAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/02/2026		A		307(1)	A	$0	17,785	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$381.96	01/02/2026		A		828(2)		01/02/2027	01/02/2036	Common Stock	828	$0	828	D

Explanation of Responses:

1. Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on January 2, 2027.

2. All of the shares of common stock underlying this stock option will vest and become exercisable on January 2, 2027.

	/s/ Michael Lynn, attorney-in-fact for Christopher A. Kuebler	01/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Waters Corp (WAT) report for Christopher A. Kuebler?

The filing reports that director Christopher A. Kuebler received a grant of 307 shares of Waters Corp common stock and a stock option for 828 shares on January 2, 2026.

How many Waters Corp (WAT) shares does the director own after this transaction?

After the reported transaction, Christopher A. Kuebler beneficially owns 17,785 shares of Waters Corp common stock, held directly.

What are the terms of the restricted stock grant for Waters Corp (WAT)?

The grant consists of 307 shares of Waters Corp common stock at $0 price, with restrictions that lapse on January 2, 2027, at which point all shares vest.

What are the key details of the Waters Corp (WAT) stock option grant?

The stock option covers 828 shares of common stock at an exercise price of $381.96 per share, vests fully on January 2, 2027, and expires on January 2, 2036.

What is Christopher A. Kuebler’s role at Waters Corp (WAT)?

Christopher A. Kuebler is reported as a Director of Waters Corp, and the Form 4 indicates the filing is made by one reporting person.

Are the reported Waters Corp (WAT) holdings direct or indirect?

Both the 17,785 shares of common stock and the 828 stock options are reported as held in direct ownership.